INTRODUCTION
A number of eukaryotic cellular proteins are found to be covalently modified with the 14-carbon saturated fatty acid, myristic acid (1) (2) (3) (4) (5) (6) . Many of the myristoylated proteins play key roles in regulating cellular structure and function. Protein N-myristoylation is the result of co-translational addition of myristic acid to a Gly residue at the extreme Nterminus after removal of the initiating Met. The requirement for Gly at the N-terminus is absolute and no other amino acid can take its place. A stable amide bond links myristic acid irreversibly to proteins. The N-myristoyltransferase (NMT) 1 which catalyzes the transfer of myristic acid from myristoyl-CoA to the N-terminal Gly has been purified and cloned from several organisms (7) (8) (9) (10) . The precise substrate specificity of this enzyme has been characterized using purified enzyme and synthetic peptide substrates (2, 11, 12) . In general, Ser or Thr is preferred at position 6 and the N-terminal consensus motifs such as
Met-Gly-X-X-X-Ser/Thr-X-X (13) or Met-Gly-X-X-X-Ser/Thr-X-X-X (5) that direct protein N-myristoylation have been defined. However, Ser or Thr at position 6 is neither sufficient nor critical for the recognition of the protein substrate by the NMT. For instance, the peptide Gly-Gln-Ala-Ala-Ala-Ala-Lys-Lys derived from the N-terminus of cAMPdependent protein kinase catalytic subunit was found to be a good substrate for the yeast NMT, and the peptide Gly-Gln-Ala-Ala-Ala-Ala-Arg-Arg was used as a reference substrate for the yeast NMT in earlier reports on the substrate specificity of this enzyme (7, Amersham, UK. The Dye Terminator Cycle Sequencing kit was from Applied Biosystems.
Anti-human TNF polyclonal antibody was purchased from R&D systems. Protein G Sepharose was from Pharmacia Biotech. Plasmid pET-22b-OVA which contains the fulllength chicken ovalbumin cDNA was provided by Dr. Akio Kato, Yamaguchi university, Japan. Other reagents purchased from Wako Pure Chemical, Daiichi Pure Chemicals, and Seikagaku Kogyo (Japan) were of analytical or DNA grade.
Plasmid construction  Plasmid pBluescript II SK(+) lacking Apa I and HinD III sites was constructed as previously described (23) , and designated pB. Plasmid pBpro-TNF, which contains the full-length human pro-TNF cDNA, and plasmid pB∆pro-TNF, containing a cDNA coding for the mature domain of TNF, were constructed as described (21, 23). Plasmid pBV2G-TNF was constructed by utilizing PCR. For this procedure, pB∆pro-TNF served as a template and two oligonucleotides (V2G, B1) as primers (Table   I) .
Table I
After digestion with Bam HI and Pst I, the amplified product was subcloned into pB at BamHI and Pst I sites. cDNAs coding for other TNF-mutants (designated R3X-TNF) in which Arg at position 3 in V2G-TNF was replaced with each of the 19 other amino acids, were constructed by a method similar to that of V2G-TNF. The mutagenic primers used in these procedures are listed in Table I . Plasmids pBGag-TNF and pBG i1 α-TNF were constructed as described previously (22) . Plasmid pBOVA which contains the full-length chicken ovalbumin cDNA was constructed by using PCR. In this case, pET-22b-OVA served as a template and two oligonucleotides (OVA-N, OVA-C) as primers (Table I) .
After digestion with Bam HI and Eco RI, the amplified product was subcloned into pB at Bam HI and Eco RI sites. cDNA coding for OVA60-TNF in which N-terminal 60 residues of ovalbumin was linked to the N-terminus of the mature domain of TNF was constructed by using PCR. For this procedure, pBOVA served as a template and two oligonucleotides (OVA-N, OVA-60) as primers (Table I) . After digestion with Bam HI and Xho I, the amplified product was subcloned into pBGag-TNF at Bam HI and Xho I sites. cDNAs coding for R3X, S6A-TNF in which Ser at position 6 in R3X-TNF mutants was replaced with Ala were constructed by using PCR. In this case, each of the pBR3X-TNF constructs served as a template and two oligonucleotides (T3, S6A) as primers (Table I) . After digestion with Sac I and Ava I, the amplified product was subcloned into pB∆pro-TNF at Sac I and Ava I sites. cDNAs coding for Gag-Q3K-TNF and G i1 α-C3K-TNF in which the amino acid at position 3 in Gag-TNF or G i1 α-TNF was replaced with Lys were constructed by using PCR. In this case, pBGag-TNF or pBG i1 α-TNF served as a template and two oligonucleotides (Gag-Q3K, B1 and Gi1-C3K, B1, respectively) as primers (Table I) .
After digestion with Bam HI and Pst I, the amplified products were subcloned into pB at
Bam HI and Pst I sites. cDNAs coding for Arf6-TNF and Hippocalcin-TNF in which Nterminal 10 residues of ∆pro-TNF was replaced with those of Arf6 or Hippocalcin were constructed by using PCR. For this procedure, pB∆pro-TNF served as a template and two oligonucleotides (Arf6, B1 and HC, B1, respectively) as primers (Table I) . After digestion with Bam HI and Pst I, the amplified products were subcloned into pB at Bam HI and Pst I sites. The DNA sequences of these recombinant cDNAs were confirmed by the dideoxynucleotide chain termination method (24) .
In vitro transcription and translation Methods essentially identical to those described previously were employed (23) . T3 polymerase was used to obtain transcripts of these cDNAs subcloned into pB vector. These were purified by phenol-chloroform extraction and ethanol precipitation prior to use. Subsequently, the translation reaction was carried out using the rabbit reticulocyte lysate (Promega) in the presence of anti-TNF antibody, the samples were analyzed by SDS-PAGE and fluorography.
Western blotting  TNF samples immunoprecipitated from in vitro translation products or total cell lysates of each group of transfected cells were resolved by 12.5 % SDS-PAGE and then transferred to an Immobilon-P transfer membrane (Millipore). After blocking with nonfat milk, the membrane was probed with a specific goat anti-hTNF antibody as described previously (25) . Immunoreactive proteins were specifically detected by incubation with horseradish peroxidase-conjugated anti-goat IgG antibody (Santa Cruz).
The membrane was developed with ECL Western blotting reagent (Amersham Corp.) and exposed to an X-ray film (Kodak). Quantitative analysis of immunoreactive proteins on the membrane was carried out using the storage phosphor imaging screen and GS-250
Molecular Imager (Bio-Rad).
Immunoprecipitation  Samples containing TNF mutants were immunoprecipitated with a specific goat anti-hTNF polyclonal antibody (R&D systems) as described (23) .
SDS-PAGE and fluorography  Samples were denatured by boiling for 3 min in SDSsample buffer followed by analysis by SDS-PAGE on a 12.5% gel. Thereafter, the gel was fixed and soaked in Amplify TM (Amersham) for 30 min. The gel was dried under vacuum and exposed to an X-ray film (Kodak) for an appropriate period. Quantitative analysis of the labeled proteins was carried out by scanning the fluorogram using an imaging densitometer (Bio-Rad GS-700). 
Analysis of bound fatty acids

RESULTS
Amino acid at position 3 in N-myristoylation consensus motif strongly affects protein N-myristoylation and N-acetylation
In order to examine the amino-terminal sequence requirements for cotranslational protein N-myristoylation, and to reveal the difference in the N-terminal sequence requirement for protein N-myristoylation and Nacetylation, the N-terminal nine residues of the mature domain of TNF including initiating
Met were changed to the N-myristoylation consensus motif, and the susceptibility to cotranslational protein N-myristoylation and N-acetylation was evaluated by an in vitro translation system. Since ∆pro-TNF, a mature domain of TNF in which the initiating Met was introduced at the N-terminus, has Met and Ser residues at positions 1 and 6, respectively, Val at position 2 was replaced with Gly to obtain V2G-TNF in which the N-terminal 9 residues were adapted to the N-myristoylation consensus motif, Met-Gly-X-X-X-Ser-X-X-X ( Fig.1 ).
Fig. 1.
As shown in Fig is suggested that the amino acid residue at position 3 in the Met-Gly-X-X-X-Ser-X-X-X motif strongly affects the susceptibility of the protein to two different cotranslational protein modifications, N-myristoylation and N-acetylation. 
Effect of lack of Ser residue at position 6 in N-myristoylation consensus motif on protein N-myristoylation and N-acetylation
It is generally accepted that Ser or Thr is preferred at position 6 for protein N-myristoylation. However, Ser or Thr at this position is neither sufficient nor critical for protein N-myristoylation. Therefore, we next examined the effect of lack of Ser residue at position 6 in N-myristoylation consensus motif on cotranslational protein N-myristoylation and N-acetylation. In this experiment, R3X,S6A-mutants in which the Ser residue at position 6 in each of R3X-mutants was changed to Ala were generated and their susceptibility to N-myristoylation and N-acetylation reaction was determined by metabolic labeling. As shown in the middle panels of Fig. 6 [B], dramatic changes in the amino acid requirement at position 3 were observed for protein Nmyristoylation. The number of amino acid residues which can direct protein Nmyristoylation was strikingly reduced ; only two amino acids, Asn and Gln, could direct efficient modification. In contrast, the number of amino acid residues that direct protein Nacetylation was increased to include Ser and Thr. These results show that the amino acid residue at position 6 strongly affects the amino acid requirement at position 3 for both protein N-myristoylation and protein N-acetylation. The susceptibility of R3X-and with Gag-TNF or G i1 α-TNF as shown in Fig. 10 (lanes 7, 8) . These results suggested that the N-myristoylation motif having Lys 3, such as that of Arf6 or Hippocalcin, might have some specific structural determinant that permits the Lys residue at position 3, while still directing protein N-myristoylation. Some amino acid preferences have been observed at distinct positions downstream of the N-terminal glycine (2, 13, 15) . In general, Ser or Thr is preferred at position 6 and N-terminal consensus motifs such as Met-Gly-X-X-X-Ser/Thr-X-X (13) or Met-Gly-X-X-X-Ser/Thr-X-X-X (5) have been defined. In addition to the preference for Ser/Thr residue at position 6, positively charged residues (lysine or arginine) are known to be preferred at positions 7 and/or 8 (2, 15). These amino acid preferences were confirmed by recent studies on the NMT structure as determined by X-ray crystallography (35) . In this study, the structure of the yeast Saccharomyces cerevisiae NMT1p was solved as a ternary complex and revealed how myristoyl CoA and peptide substrates bind to the enzymes. The determined structure allows identification of specific residues within NMT that serve to restrict substrate specificity to 14-carbon fatty acids and account for the preference of Gly-2, Ser-6, and basic amino acids at positions 7 and 8 of the peptide substrate.
Amino acid requirements for protein N-myristoylation found in the in vitro translation system are applicable to the protein N-myristoylation in intact cells
In the present study, in order to examine the amino-terminal sequence requirements for the cotranslational N-myristoylation of proteins, several series of mutants were prepared by site-directed mutagenesis of the N-terminal region of the protein, using tumor necrosis factor (TNF) as a non-myristoylated model protein. Subsequently, the susceptibility of these mutants to the cotranslational N-myristoylation reaction was evaluated by an in vitro transcription/ translation system using the rabbit reticulocyte lysate. It was found that the radius of gyration of the amino acid residue at position 3 in an N-myristoylation consensus motif, Met-Gly-X-X-X-Ser-X-X-X, strongly affected the cotranslational protein N-myristoylation. Amino acids with a radius of gyration larger than cDNA coding for ∆pro-TNF which contains the mature domain of TNF was first generated from pro-TNF cDNA by deleting the nucleotide sequence encoding the propeptide region of pro-TNF. Subsequently, V2G-TNF cDNA was generated from ∆pro-TNF cDNA by site-directed mutagenesis. The mRNAs encoding Gag-, G i1 α-, R3A-, R3D-, OVA60-TNF, and ovalbumin were translated in vitro in the presence of [ Table   Table I 
